15 views 0 likes

Live Event Content

GCMD Space · View profile →

2025 Pediatric Surgery Update Course - Updates in Colorectal: Debunking Dogma

Video Published 2025-08-28 Updated 2026-08-01

Timestops (6)

Topic Overview

A panel discussion on current controversies in pediatric colorectal surgery, focusing on timing and technique for anorectal malformation repair and Hirschsprung disease management. The faculty debate neonatal versus delayed posterior sagittal anorectoplasty (PSARP), perineal body-preserving techniques, the role of postoperative anal dilations, optimal timing for Hirschsprung pull-through procedures, and use of botulinum toxin. Recent multi-institutional data suggest both early and delayed PSARP are safe for vestibular fistulas, perineal body-preserving approaches may reduce wound complications, and routine postoperative dilations may not be necessary. The panel emphasizes shared decision-making with families and acknowledges significant practice variation across institutions.

Key Takeaways

  • Early vs delayed PSARP for vestibular fistulas show similar 30-day outcomes; timing can be individualized per family preference. (5:14)
  • Perineal body-preserving PSARP reduces wound complications with no dehiscence and allows earlier discharge without added operative time. (10:22)
  • Routine post-PSARP dilations may not be necessary; observation vs dilation groups show similar stricture rates requiring reoperation. (18:01)
  • Neonatal vs delayed Hirschsprung pull-through have comparable enterocolitis and incontinence rates; timing can be tailored to family needs. (20:25)
  • Botox at pull-through may reduce early enterocolitis risk (30% vs 50%) but increases diaper rash; ultrasound guidance optimizes placement. (23:58)

Inside this episode

Kai, the Library's AI content creator, listened to this episode and mapped who's speaking, the chapters, key claims, and cases. Every item links to the exact moment in the recording.

AI-enriched

Who's speaking

  • Nelson Rosen — host
  • Jamie Harris — guest
  • Speaker 3 — guest

Chapters

  • 0:00Introduction and Case 1: Timing of PSARP for Vestibular Fistula — Faculty introduce the colorectal update session and present a case of a term female with recto-vestibular fistula. Discussion centers on whether to perform neonatal PSARP versus delayed repair after discharge, with audience polling showing preference for delayed approach.
  • 9:07Perineal Body-Preserving PSARP Technique — Panel discusses the perineal body-preserving PSARP approach, including technical considerations for avoiding vaginal wall injury, learning curve challenges, and evidence showing no increase in operative time or complications compared to traditional PSARP.
  • 15:49Postoperative Anal Dilations Controversy — Debate on routine postoperative anal dilations after PSARP. Panel reviews evidence showing similar stricture rates with and without dilations, discusses family burden and PTSD associated with dilations, and presents stricturoplasty as alternative management.
  • 19:30Case 2: Timing of Hirschsprung Pull-Through — Discussion of optimal timing for Hirschsprung pull-through in term newborn. Panel emphasizes importance of family competence with irrigations, considers length of aganglionic segment, and reviews data showing no difference in enterocolitis rates between neonatal and delayed approaches.
  • 24:27Botulinum Toxin Use in Hirschsprung Disease — Panel discusses injection of botulinum toxin at time of pull-through, including dosing strategies, ultrasound guidance techniques, and preliminary data suggesting reduced early enterocolitis but increased diaper rash.
  • 26:35Case 3: Hirschsprung Disease and Anorectal Malformations — Brief discussion of concurrent Hirschsprung disease and anorectal malformations, occurring in approximately 2% of ARM cases. Panel reviews interpretation of ganglion cells in fistula tissue and screening indications in patients with chromosomal anomalies.

Key claims

  • 5:14Two studies in 2021 found no difference in wound complications, re-operations, or readmissions between early (less than 7-14 days) and delayed (6 weeks to 8 months) PSARP for vestibular fistulas — Jamie Harris
  • 6:00Wound breakdown and dehiscence was the most common complication in both neonatal and delayed PSARP groups, occurring in approximately 5-6% with no significant difference between groups — Jamie Harris
  • 2:33For vestibular fistula dilations, recommend only dilating to 7 Hegar to decrease potential scarring along the tract for future PSARP — Jamie Harris
  • 10:22Perineal body-preserving PSARP showed no dehiscence, no prolapse, and only 13% required revision of anal stenosis at one-year follow-up in 2023 publication — Speaker 3
  • 10:36Two-thirds of patients undergoing perineal body-preserving PSARP went home on postoperative day one — Speaker 3
  • 14:03Perineal body-preserving PSARP does not add operative time compared to standard PSARP — Jamie Harris
  • 16:31Anal dilations are associated with parental anxiety, PTSD for both patients and caregivers, and post-traumatic stress symptoms in families — Speaker 3
  • 17:00Preoperative dilations appear to be more tolerated than postoperative dilations — Speaker 3
  • 17:19In Spanish study, children adequately sized at initial post-PSARP appointment did not receive dilations, while undersized children received dilations — Speaker 3
  • 18:01Single institution review showed 2 children in each group (dilations vs no dilations) required re-operation for neoanal stricture, and approximately 15% required Heineke-Mikulicz stricturoplasty — Speaker 3
  • 20:25PCPLC retrospective study of Hirschsprung disease found no difference in preoperative enterocolitis, postoperative enterocolitis, or fecal incontinence between neonatal pull-through (median 11 days) and delayed primary pull-through (median 98 days) — Nelson Rosen
  • 23:40Multi-center retrospective study found 24% of Hirschsprung patients received at least one Botox injection — Nelson Rosen
  • 23:58Cincinnati Children's prospective study (2020-2024, unpublished) found decreased risk of enterocolitis within 31 days after pull-through in patients receiving Botox (30% vs 50%) — Nelson Rosen
  • 24:23Patients receiving Botox at time of pull-through had higher risk of diaper rash (60%) — Nelson Rosen
  • 24:58Early work from Boston used per-kilogram Botox dosing up to maximum of 100 units — Nelson Rosen
  • 27:03Rate of concurrent Hirschsprung disease and anorectal malformation is approximately 2% based on Pena's series — Speaker 3
  • 27:14Some papers show rate of concurrent Hirschsprung and ARM as high as 3-4%, while recent paper showed less than 1% — Speaker 3
  • 27:39Single center study found ganglion cells in 90% of rectal fistula specimens taken during PSARP, with hypoganglionosis or absent ganglion cells in the rest — Speaker 3
  • 28:24Patients with both Hirschsprung disease and anorectal malformation tend to have chromosomal anomalies, particularly trisomy 21 — Speaker 3
  • 8:41Fistula dilations represent controlled tears when starting from pinhole size, not true stretching — Nelson Rosen
  • 4:17Goal of fistula dilation is to maintain patency just large enough for soft, mustardy stool to pass through — Nelson Rosen
  • 11:04Perineal body-preserving PSARP is essentially the same technique used for bulbar fistula applied to vestibular fistula — Nelson Rosen
  • 11:32Key technical principle for perineal body-preserving PSARP is to mobilize lateral planes and back wall thoroughly before coming around the anterior common plane — Nelson Rosen
  • 13:09Perineal body-preserving PSARP can be converted to standard PSARP by extending the incision if visualization is inadequate — Jamie Harris
  • 21:36Families competent with irrigations will start treatment for enterocolitis before calling the surgeon — Speaker 3
  • 22:07Patients with longer aganglionic segments who cannot be adequately decompressed at home may require earlier pull-through to prevent enterocolitis or perforation — Speaker 3
  • 22:39Some data suggests possibly better continence in delayed Hirschsprung pull-through group, but studies have been underpowered — Speaker 3
  • 25:48Ultrasound guidance for Botox injection allows visualization of needle placement, internal and external anal sphincter layers, superficial external anal sphincter, and sometimes puborectalis — Speaker 3
  • 27:54Absence of ganglion cells in fistula tissue does not necessarily mean Hirschsprung disease, as fistula tissue is not physiologic tissue — Speaker 3

Cases discussed

  • 1:44Term female infant, 3 kg, with recto-vestibular fistula and negative vertebral workup
  • 19:32Term newborn with delayed meconium passage and Hirschsprung disease diagnosed by suction rectal biopsy

Points of disagreement

  • 3:38Timing of PSARP for vestibular fistula
    • Nelson Rosen: Prefers neonatal PSARP during initial NICU admission if no comorbidities and adequate weight, considers this 'old school' approach
    • Speaker 3: Prefers delayed approach between 1-3 months, allowing baby to go home and grow bigger, making surgery technically easier
  • 15:49Routine postoperative anal dilations after PSARP
    • Nelson Rosen: Routinely performs dilations
    • Speaker 3: Questions the paradigm of routine dilations given family burden and lack of clear benefit in recent data
    • Jamie Harris: Dilates for neonates but holds off for older ambulatory children due to trauma
  • 21:03Timing of Hirschsprung pull-through
    • Jamie Harris: Delays at least 1-3 months to ensure families demonstrate competence with irrigations
    • Speaker 3: Previously did all in NICU but has shifted to more delayed approach, though still individualizes based on family situation

Open questions

  • What is the optimal weight cutoff for neonatal PSARP (2.5 kg, 2 kg, 1.5 kg)?
  • What is the optimal dosing strategy for botulinum toxin in Hirschsprung disease - weight-based versus fixed dose?
  • Does length of aganglionic segment affect optimal timing of pull-through?
  • What is the true rate of concurrent Hirschsprung disease and anorectal malformation (estimates range from <1% to 4%)?
  • How much rectal mobilization is necessary during PSARP to balance adequate repair with preservation of innervation and blood supply?
This episode was analyzed and enriched by Kai, the Library's AI content creator. Every item links to the moment it comes from — click a timestamp to listen in context.
Written for:

Vestibular Fistula in a Term Neonate: Choosing Between Early and Delayed Repair

The patient case from this episode, retold from presentation to outcome with the decisions made along the way. Written by Kai from the episode transcript and reviewed before publishing.

For the care team · Case narrative · AI-written, human-reviewed

The presentation

A term female infant weighing 3 kg presented with a recto-vestibular fistula [case1]. The vertebral workup was completely negative aside from the anorectal malformation itself [case1]. The fistula was calibrated with a 7 Hegar dilator and was decompressing adequately [case1].

The decision point

The question was timing: perform a posterior sagittal anorectoplasty (PSARP) during the neonatal admission, or send the infant home on fistula dilations and return for repair at one to three months of age [case1].

This is not a question with a single correct answer 5:14. Two studies published in 2021 found no difference in wound complications, re-operations, or readmissions between early repair (less than 7-14 days of life) and delayed repair (6 weeks to 8 months) 5:14. Wound breakdown and dehiscence occurred in approximately 5-6% of patients in both groups, with no significant difference 6:00. The evidence supports either approach as safe 5:14 6:00.

The choice turns on surgical philosophy and family circumstances [case1]. One discussant favored neonatal repair when feasible, arguing that if the infant can be decompressed with fistula dilations and has no significant comorbidities, completing the repair before discharge avoids a second admission [case1]. The counterargument: delaying allows the infant to grow larger, which may make the operation technically easier, and gives the family time at home before surgery [case1].

If dilations are performed preoperatively, the goal is narrow: maintain patency just large enough for soft, mustardy stool to pass through 4:17. Dilating beyond a 7 Hegar risks creating scarring along the fistula tract that complicates the definitive repair 2:33. The term "dilation" is somewhat misleading when the fistula starts as a pinhole — it is a controlled tear, not true stretching 8:41.

What the team actually did

The discussants described their institutional approaches, which varied [case1]. One center routinely performs neonatal PSARP when the infant is stable and adequately sized, typically within the first week of life [case1]. Another center prefers to delay repair to one to three months, allowing the infant to go home and the family to demonstrate competence with fistula dilations before returning for surgery [case1]. Both approaches were described as safe and effective [case1].

For the repair itself, several discussants have adopted the perineal body-preserving PSARP technique, which applies the principles used for bulbar fistulas to vestibular fistulas 11:04. The key technical principle is thorough mobilization of the lateral planes and posterior wall before addressing the anterior common plane between rectum and vagina 11:32. In a 2023 publication, this approach resulted in no dehiscence, no prolapse, and only a minority of patients requiring revision for anal stenosis at one-year follow-up 10:22. Two-thirds of patients went home on postoperative day one 10:36. The operation does not add time compared to standard PSARP 14:03. If visualization proves inadequate, the incision can be extended to convert to a standard PSARP 13:09.

What happened

Outcome data for the specific case presented were not discussed [case1].

What the case changes

The evidence base now supports flexibility in timing for vestibular fistula repair 5:14. The traditional approach of routine neonatal PSARP is safe, but so is delayed repair after discharge 5:14 6:00. The choice can be individualized based on infant size, family readiness, and surgeon preference, rather than adhering to a single protocol [case1].

The perineal body-preserving technique represents a technical refinement that may reduce morbidity — shorter hospital stays, potentially lower rates of wound complications — without adding operative time or complexity for surgeons familiar with PSARP principles 10:22 10:36 14:03. The ability to convert to a standard approach if needed makes it a low-risk modification to adopt 13:09.

The broader lesson is that fistula dilations, whether preoperative or postoperative, should be performed with restraint 2:33 4:17. Dilations are associated with parental anxiety, PTSD in both patients and caregivers, and post-traumatic stress symptoms in families 16:31. Preoperative dilations appear to be better tolerated than postoperative dilations 17:00. Maintaining minimal patency for decompression, rather than aggressive dilation to larger sizes, respects both the anatomy and the family's experience 4:17 16:31 17:00.

Takeaways from this story

  • Early and delayed PSARP for vestibular fistulas show equivalent 30-day complication rates, allowing individualized timing decisions.
  • Perineal body-preserving PSARP achieves low rates of anal stenosis revision at one year with two-thirds discharged on postop day one.
  • Limit preoperative fistula dilations to 7 Hegar to minimize tract scarring; goal is minimal patency for soft stool passage, not aggressive sizing.
  • Fistula dilations cause significant family distress; preoperative dilations are better tolerated than postoperative protocols.

Keywords

Hashtags

Transcript

Comments

Loading comments…